Mironid® Limited

United Kingdom - North Lanarkshire

• 14/09/2023
• Series A
• Undisclosed Amount

Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows us to access multiple therapeutic areas for exploitation. Our current drug discovery pipeline is aimed at developing novel treatments for degenerative kidney diseases, chronic inflammatory diseases and cancer.

Related People

Neil WilkieFounder

United Kingdom - Greater Glasgow Area

Experienced C-level Pharmaceutical Executive with extensive experience of technical drug discovery combined with investment and company building experience. Graduate of MIT's Global Entrepreneurship Development Program.

Dynamic and versatile with 25+ years’ experience of delivering value from investments in the pharmaceutical and biotechnology sectors. A high-energy enthusiastic leader with a strong strategic aptitude and relationship-building style who leads with the end-goal in mind, utilising established senior-level networks, a proven history of leadership and a track record of channeling strategic vision into defined plans of action.

Specialties: Pharmaceutical Drug Development, Company Creation & Building, Business and Investment Analysis, Corporate Programme Management.

LinkedIn https://www.linkedin.com/in/neil-wilkie-127aa5/